- Moody's•7 hours ago
New York, February 23, 2017-- Moody's Investors Service assigned a Baa3 rating to Abbott Laboratories' proposed new senior unsecured note offering. The rating outlook is stable. There are no changes to ...
- Benzinga•16 days ago
Abbott Laboratories (NYSE: ABT )'s acquisition of St. Jude Medical Inc (previously traded (NYSE: STJ ) doesn't erase an ongoing concerns shared by many investor, which were brought into the spotlight by ...
- Barrons.com•21 days ago
Shares of Boston Scientific (BSX) shot more than 4% higher today after the medical device maker unveiled fourth quarter financial results that beat expectations. “Boston Scientific ended 2016 on a very good note, and enters 2017 with a promising product pipeline and lots of momentum to avoid a sophomore slump,” writes Joanne Wuensch, an analyst at BMO Capital Markets. The company says it will earn between $1.22 a share and $1.26 a share compared to consensus of $1.25 a share.
STJ : Summary for St. Jude Medical, Inc. - Yahoo Finance
St. Jude Medical, Inc. (STJ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||35.14|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|